ASSAY and Drug Development Technologies
Impact Factor Trend (2018–2026)
Clarivate IF trend for ASSAY and Drug Development Technologies
SCImago Journal Rank citation prestige weighting
68 papers with at least that number of citations each
Aims & Scope
ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: -Assay design, target development, and high-throughput technologies- Hit to Lead optimization and medicinal chemistry through preclinical candidate selection- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis- Approaches to assays configured for gene families, inherited, and infectious diseases- Assays and strategies for adapting model organisms to drug discovery- The use of stem cells as models of disease- Translation of phenotypic outputs to target identification- Exploration and mechanistic studies of the technical basis for assay and screening artifacts
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
BIOCHEMICAL RESEARCH METHODS
PHARMACOLOGY & PHARMACY
BIOCHEMICAL RESEARCH METHODS
PHARMACOLOGY & PHARMACY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisASSAY and Drug Development Technologies (abbr: ASSAY DRUG DEV. TECHNOL, ISSN: 1540-658X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.327 (Q3), an H-index of 68.
The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 39 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,730 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics